Plasmin, a broad spectrum protease, may be important to the pathogenesis of inflammatory tissue injury and the subsequent repair process. Plasmin activity is regulated partly by plasminogen activators (PA) and plasminogen activator inhibitors (PAI). This proposal is based on the hypothesis that abnormal expression of plasmin activity may influence the course of acute an chronic lung inflammation. further, pulmonary macrophages may regulate plasmin activity in the lung by producing both PA and PAI proteins. The proposed experiments are designed to determine whether PA and PAI activities are expressed abnormally in human lung diseases, including the adult respiratory distress syndrome, pulmonary sarcoidosis, usual interstitial pneumonitis, and emphysema. Secondly, human alveolar macrophages and macrophage-like U937 cells will be studied in vitro to characterize regulatory steps in the biosynthesis and secretion of PA and PAI proteins. Cells will be cultured in vitro and subjected to a range of stimuli designed to alter PA and PAI expression. The proteins will be characterized by functional (esterolytic) assays, fibrin-agar enzymography, ELISA, and Western blotting. To characterize the biosynthesis of these proteins, steady-state mRNA will be characterized by Northern blot analysis and dot-blotting. The rate of gene transcription will be determined by measuring pulse-labeled transcription by isolated nuclei. Alveolar macrophages and fluid will be obtained by bronchoalveolar lavage of the human subjects, and the PA and PAI activities characterized by the immunochemical and biochemical methods used in the in vitro studies. Specific mRNA for PA and PAI proteins will also be measured in alveolar macrophages. If abnormalities in PA or PAI expression can be identified in any of these lung diseases, this information will contribute greatly to understanding the role of plasmin in lung inflammation. These studies should also expand on present knowledge of the mechanisms by which macrophages regulate expression of inflammatory proteases.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL039672-01
Application #
3356476
Study Section
Pathology A Study Section (PTHA)
Project Start
1988-04-01
Project End
1991-03-31
Budget Start
1988-04-01
Budget End
1989-03-31
Support Year
1
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Sitrin, R G; Todd 3rd, R F; Albrecht, E et al. (1996) The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes. J Clin Invest 97:1942-51
Sitrin, R G; Shollenberger, S B; Strieter, R M et al. (1996) Endogenously produced urokinase amplifies tumor necrosis factor-alpha secretion by THP-1 mononuclear phagocytes. J Leukoc Biol 59:302-11
Gyetko, M R; Sitrin, R G; Fuller, J A et al. (1995) Function of the urokinase receptor (CD87) in neutrophil chemotaxis. J Leukoc Biol 58:533-8
Varani, J; Perone, P; Inman, D R et al. (1995) Human skin in organ culture. Elaboration of proteolytic enzymes in the presence and absence of exogenous growth factors. Am J Pathol 146:210-7
Mizukami, I F; Faulkner, N E; Gyetko, M R et al. (1995) Enzyme-linked immunoabsorbent assay detection of a soluble form of urokinase plasminogen activator receptor in vivo. Blood 86:203-11
Gyetko, M R; Todd 3rd, R F; Wilkinson, C C et al. (1994) The urokinase receptor is required for human monocyte chemotaxis in vitro. J Clin Invest 93:1380-7
Mody, C H; Chen, G H; Jackson, C et al. (1994) In vivo depletion of murine CD8 positive T cells impairs survival during infection with a highly virulent strain of Cryptococcus neoformans. Mycopathologia 125:7-17
Sitrin, R G; Todd 3rd, R F; Mizukami, I F et al. (1994) Cytokine-specific regulation of urokinase receptor (CD87) expression by U937 mononuclear phagocytes. Blood 84:1268-75
Mody, C H; Chen, G H; Jackson, C et al. (1993) Depletion of murine CD8+ T cells in vivo decreases pulmonary clearance of a moderately virulent strain of Cryptococcus neoformans. J Lab Clin Med 121:765-73
Varani, J; Sitrin, R G; Hillegas, W (1992) Expression of plasminogen activator and plasminogen activator inhibitor mRNA in human fibroblasts grown on different substrates. Cytotechnology 9:157-62

Showing the most recent 10 out of 22 publications